Physician profile
Jackson Lau
NPI 1306903067
$4,750.20
in general payments reported to CMS, 2019-2025
19 companies · $421 in 2025
The $421 reported for 2025 was more than what 78% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,720 · 2020: $526 · 2021: $634 · 2022: $188 · 2023: $549 · 2024: $713 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,736.83 | 2019-2025 | Dailies Total1, Precision 1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $1,103.98 | 2019-2025 | Acuvue |
| Abb Con-Cise Optical Group LLC | $353.02 | 2019-2021 | |
| Coopervision INC. | $313.73 | 2019-2025 | Myday Contact Lens |
| Visioneering Technologies, INC. | $300.10 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $140.83 | 2020-2025 | Cequa |
| Oyster Point Pharma, INC. | $131.63 | 2022-2025 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $127.97 | 2019-2020 | |
| Optovue, INC. | $95.84 | 2019 | |
| Dompe US, INC. | $92.82 | 2020-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $76.33 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $66.30 | 2020 | |
| Glaukos Corporation | $54.23 | 2020 | |
| Allergan, INC. | $49.47 | 2020-2022 | |
| Lombart Brothers, INC. | $29.93 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.05 | 2022 | |
| Shire North American Group INC | $20.96 | 2019 | |
| Biotissue Holdings INC. | $20.09 | 2020 | |
| Eyevance Pharmaceuticals LLC | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.